Future prospect of“Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”

Yong-Bo Kang; Yue Cai

首页> 中文期刊> 《世界胃肠病学杂志：英文版》 >Future prospect of“Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”

Future prospect of“Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”

开具论文收录证明 >>

期刊封面封底目录下载 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Recently,we read the article“Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”with interest,and it is preliminary suggested that gut microbiota is closely related to therapeutic effect of nivolumab.Based on the meaningful results of this article,several valuable research directions are proposed to enhance the therapeutic effect of immune checkpoint inhibitors on advanced hepatocellular carcinoma.

著录项

来源
《世界胃肠病学杂志：英文版》 |2022年第20期|2248-2250|共3页
作者
Yong-Bo Kang; Yue Cai;
展开▼
作者单位

Department of Microbiology and Immunology of Basic Medical Sciences Medical University 030600 Province;

展开▼
原文格式 PDF
正文语种 chi
中图分类肿瘤学;
关键词
Gut microbiome; Immunotherapy; Immune checkpoint inhibitor resistance; PROBIOTICS; Faecal microbiota transplantation; Hepatocellular carcinoma; Prognosis;

相似文献

中文文献
外文文献

Future prospect of“Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”

摘要

著录项

相似文献

相关主题

期刊订阅